Literature DB >> 10067964

In vivo significance of ICAM-1--dependent leukocyte adhesion in early corneal angiogenesis.

M D Becker1, F E Kruse, L Azzam, R Nobiling, J Reichling, H E Völcker.   

Abstract

PURPOSE: Numerous investigations have stressed the significance of leukocytes in early angiogenesis. Leukocytes invade the cornea, and the location of their extravasation corresponds to the site of vessel ingrowth. The interactions between leukocytes and vascular endothelium are mediated by various proteins, including adhesion molecules such as intercellular adhesion molecule-1 (ICAM-1). In this study, the role of ICAM-1 during early corneal angiogenesis was evaluated in vivo.
METHODS: Corneal neovascularization was induced in New Zealand White rabbits by use of intrastromal pellets containing 750 ng vascular endothelial growth factor (VEGF). The fluorescent dye rhodamine 6G was used to stain leukocytes in vivo. Leukocyte adhesion and vessel growth were quantified in vivo by high-resolution fluorescence angiography. To inhibit ICAM-1 interactions a microemulsion containing anti-ICAM-1 antibody was applied topically.
RESULTS: Limbal vessels showed increased leukocyte adhesion 24 hours after pellet implantation: The number of rolling and sticking leukocytes was significantly increased compared with the number in control animals (P < 0.01). Treatment with anti-ICAM-1 antibody resulted in reduced leukocyte sticking and increased leukocyte rolling. The area covered by new blood vessels was significantly diminished in eyes treated with anti-ICAM-1 (P < 0.05).
CONCLUSIONS: The results support the hypothesis that ICAM-1-mediated leukocyte adhesion is a key event in early angiogenesis. This model may serve for investigation of the significance of adhesion molecules by in vivo observation and quantification.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10067964

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  8 in total

1.  CD18 and ICAM-1-dependent corneal neovascularization and inflammation after limbal injury.

Authors:  Y Moromizato; S Stechschulte; K Miyamoto; T Murata; A Tsujikawa; A M Joussen; A P Adamis
Journal:  Am J Pathol       Date:  2000-10       Impact factor: 4.307

2.  Intrachoroidal neovascularization in transgenic mice overexpressing vascular endothelial growth factor in the retinal pigment epithelium.

Authors:  C Schwesinger; C Yee; R M Rohan; A M Joussen; A Fernandez; T N Meyer; V Poulaki; J J Ma; T M Redmond; S Liu; A P Adamis; R J D'Amato
Journal:  Am J Pathol       Date:  2001-03       Impact factor: 4.307

3.  Vascular endothelial growth factor (VEGF)-induced retinal vascular permeability is mediated by intercellular adhesion molecule-1 (ICAM-1).

Authors:  K Miyamoto; S Khosrof; S E Bursell; Y Moromizato; L P Aiello; Y Ogura; A P Adamis
Journal:  Am J Pathol       Date:  2000-05       Impact factor: 4.307

4.  lncRNA MIAT suppression alleviates corneal angiogenesis through regulating miR-1246/ACE.

Authors:  Yanhui Bai; Weiqun Wang; Youmei Zhang; Fengyan Zhang; Haohao Zhang
Journal:  Cell Cycle       Date:  2019-03-05       Impact factor: 4.534

5.  Minodronate, a newly developed nitrogen-containing bisphosphonate, suppresses melanoma growth and improves survival in nude mice by blocking vascular endothelial growth factor signaling.

Authors:  Sho-ichi Yamagishi; Riichiro Abe; Yosuke Inagaki; Kazuo Nakamura; Hiroshi Sugawara; Daisuke Inokuma; Hideki Nakamura; Tadamichi Shimizu; Masayoshi Takeuchi; Akihiko Yoshimura; Richard Bucala; Hiroshi Shimizu; Tsutomu Imaizumi
Journal:  Am J Pathol       Date:  2004-12       Impact factor: 4.307

6.  MK2 inhibitor reduces alkali burn-induced inflammation in rat cornea.

Authors:  Yanfeng Chen; Wenzhao Yang; Xiaobo Zhang; Shu Yang; Gao Peng; Ting Wu; Yueping Zhou; Caihong Huang; Peter S Reinach; Wei Li; Zuguo Liu
Journal:  Sci Rep       Date:  2016-06-22       Impact factor: 4.379

Review 7.  Endothelial cell dysfunction, coagulation, and angiogenesis in coronavirus disease 2019 (COVID-19).

Authors:  Amir Hossein Norooznezhad; Kamran Mansouri
Journal:  Microvasc Res       Date:  2021-05-19       Impact factor: 3.514

8.  Topical application of TAK1 inhibitor encapsulated by gelatin particle alleviates corneal neovascularization.

Authors:  Jiang-Hui Wang; Ching-Li Tseng; Fan-Li Lin; Jinying Chen; Erh-Hsuan Hsieh; Suraj Lama; Yu-Fan Chuang; Satheesh Kumar; Linxin Zhu; Myra B McGuinness; Jessika Hernandez; Leilei Tu; Peng-Yuan Wang; Guei-Sheung Liu
Journal:  Theranostics       Date:  2022-01-01       Impact factor: 11.556

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.